Subscribe
17 July 2017Big Pharma

DLA Piper hires patent litigator in Germany

DLA Piper has hired patent litigator Philipp Cepl as a partner in its German patent practice.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

article
Why you shouldn’t overlook Canadian IP litigation
2 October 2017   Canada has a robust and reliable framework for resolving IP disputes, and it shouldn’t be ignored by litigants, say Ron Dimock, Sangeetha Punniyamoorthy and Nikolas Purcell of DLA Piper.
Big Pharma
DLA Piper announces new life sciences Dublin office amid Brexit
16 May 2018   UK-based law firm DLA Piper has announced that it will open a new office in Dublin, Ireland in light of Brexit.


Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024

Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024

More on this story

Big Pharma
DLA Piper announces new life sciences Dublin office amid Brexit
16 May 2018   UK-based law firm DLA Piper has announced that it will open a new office in Dublin, Ireland in light of Brexit.
article
Why you shouldn’t overlook Canadian IP litigation
2 October 2017   Canada has a robust and reliable framework for resolving IP disputes, and it shouldn’t be ignored by litigants, say Ron Dimock, Sangeetha Punniyamoorthy and Nikolas Purcell of DLA Piper.

More on this story

Big Pharma
DLA Piper announces new life sciences Dublin office amid Brexit
16 May 2018   UK-based law firm DLA Piper has announced that it will open a new office in Dublin, Ireland in light of Brexit.
article
Why you shouldn’t overlook Canadian IP litigation
2 October 2017   Canada has a robust and reliable framework for resolving IP disputes, and it shouldn’t be ignored by litigants, say Ron Dimock, Sangeetha Punniyamoorthy and Nikolas Purcell of DLA Piper.

More features

Chinese biotech takes out US rival’s nucleic acid patent at PTAB
Attorney v examiner: Navigating patenting's AI tools ‘arms race’
Lewis Roca promotes tech expert to managing partner
Panitch Schwarze brings in molecular biologist
US targets ‘product hopping’ with biologic litigation curbs
UPC confirms validity of Edwards Lifesciences heart valve tech patent
ITC concludes row over biotech lab equipment between US and German rivals
UKIPO launches ‘revolutionary’ patent filing and AI tool